Healthcare News Georgia Governor Criticized For Planning To Reopen State Amid Coronavirus Outbreak 5 years ago
New Drugs FDA Approves Zejula (niraparib) as the Only Once-Daily PARP Inhibitor in First-Line Monotherapy Maintenance Treatment for Women with Platinum-Responsive Advanced Ovarian Cancer Regardless of Biomarker Status 5 years ago